Longeveron

Longeveron is a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions.

Industries

Biotechnology

Headquarters

Miami, United States

Stage

IPO

Employees

11-50

Links

Org chart

Wa'el Hashad

CEO

Collapse

Joshua M. Hare

Co-Founder, Chief Science Officer & Chairman

Chris Min

Chief Medical Officer

James Clavijo

Chief Financial Officer

Dan Gincel

SVP, Strategic Collaborations & Scientific Affairs

Lisa McClain-Moss

VP, Manufacturing

Jerome Bailey

VP of Business Operations

Jessica Protenic

Senior Director Patient Services

Elba Lozado

Senior Admin Assistant & Office Manager

Teams

View all

Board of Directors

12 members

Leadership Team

7 members

CEO and Executive Team

4 members

Founding Team

1 members

Discover similar companies

Second Genome

South San Francisco, United States · Grant

Aridis Pharmaceutical

San Jose, United States · Post IPO Equity

Seeding Labs

Boston, United States · Grant

Caladrius Biosciences

Basking Ridge, United States · IPO

Sanguine

Los Angeles, United States · Grant

Envisagenics

New York, United States · Grant

Paradromics

San Jose, United States · Venture

New Age Meats

Berkeley, United States · Series A

Lantern Pharma

Dallas, United States · IPO

Raptor Maps

Somerville, United States · Series B

ECHO

San Diego, United States · Series A

HistoWiz

NY, United States · Series A

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.